Chimerix (CMRX)
(Delayed Data from NSDQ)
$0.94 USD
0.00 (-0.27%)
Updated May 28, 2024 04:00 PM ET
After-Market: $0.94 0.00 (0.48%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth B Momentum D VGM
Brokerage Reports
Chimerix, Inc. [CMRX]
Reports for Purchase
Showing records 41 - 60 ( 115 total )
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
HEALTHCARE- The Week Ahead in Life Sciences
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Chimerix, Inc.
Industry: Medical - Products
1Q22 Results; Worldwide Rights to Tembexa Sold; DSTAT Development Discontinued
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
FY23 Congressional Justification for Health and Social Services Emergency Fund Out
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
4Q21 Results; BARDA Contract Could Be Announced Soon
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Data for ONC201 in Neuroendocrine Tumors Patients Published
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Chimerix, Inc.
Industry: Medical - Products
BARDA Issues RFP to Chimerix for Smallpox Antiviral Tembexa
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Chimerix, Inc.
Industry: Medical - Products
Highlights From Non-Deal Roadshow; Raise PT to $24
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E